Physician profile
Timothy G Dutra
NPI 1588650162
$1,482.23
in general payments reported to CMS, 2019-2025
10 companies · $263 in 2025
The $263 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $636 · 2020: $107 · 2021: $125 · 2022: $256 · 2023: $95.77 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $358.79 | 2019-2021 | |
| Musculoskeletal Transplant Foundation INC. | $202.44 | 2020-2023 | |
| Zimmer Biomet Holdings, INC. | $142.20 | 2022 | |
| Treace Medical Concepts, INC. | $135.68 | 2025 | |
| Bioventus LLC | $127.02 | 2025 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $124.98 | 2019 | |
| Orthofix Medical, INC. | $113.70 | 2022 | |
| Smith+Nephew, INC. | $93.23 | 2019 | |
| Osiris Therapeutics INC. | $92.13 | 2019 | |
| Crossroads Extremity Systems, LLC | $92.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Dutra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.